Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1COVID-19 1

Interventions

Standard of Care 2Hydroxychloroquine 2tocilizumab 1remdesivir 1palbociclib 1ogalvibart 1crexavibart 1cilgavimab and tixagevimab drug combination 1Practice Guidelines as Topic 1Immunoglobulin G 1Disulfides 1Blood Specimen Collection 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × COVID-19 × remdesivir × Clear all
NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Klinikum Bremen-Mitte, gGmbH

Phase 2/3 Withdrawn
Lymphoid

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡